|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows From Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Provision for credit losses | ||
| Depreciation and amortization | ||
| Inventory writedown | ||
| Gain on disposal of equipment | ||
| Impairment expense | ||
| Interest capitalized to line of credit | ||
| Stock-based compensation | ||
| Share issuance for services | ||
| Loss on write-off of assets | ||
| Operating right of use assets and liabilities | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Inventories | ||
| Prepaid expenses and other current assets | ||
| Right-of-use liabilities | ||
| Deposits | ||
| Deferred tax asset | ||
| Accounts payable | ||
| Deferred revenue | ||
| Contracts payable | ||
| Other liabilities | ||
| Accrued employee benefits | ||
| Net cash used in operating activities | ||
| Cash Flows From Investing Activities: | ||
| Purchases of equipment | ||
| Net activity on due from related parties | ||
| Proceeds from disposals of equipment | ||
| Net cash provided by (used in) investing activities | ||
| Issuance of ordinary share, net of issuance costs | ||
| Proceeds from issuance of shares, net | ||
| Proceeds from notes payable - related parties | ||
| Repayments of notes payable - related parties | ||
| Proceeds from notes payable | ||
| Repayments of notes payable | ||
| Proceeds from issuance of convertible notes payable - related party | ||
| Net cash provided by financing activities | ||
| Effect of exchange rate changes on cash | ||
| Net increase (decrease) in cash | ||
| Cash at beginning of year | ||
| Cash at end of year | ||
| Supplemental Disclosure of Cash Flow Information: | ||
| Cash paid for interest | ||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | ||
| Ordinary shares issued in settlement of other liabilities | ||
| Ordinary shares issued upon conversion of convertible notes | ||
| Ordinary shares issued to settle accrued expenses | ||
| Equipment acquired through issuance of note payable | ||
| Forgiveness of liability for shares to be issued | ||
| Reclassification of previously capitalized IPO costs to equity upon completion of IPO | ||
| Operating right-of-use asset acquired in exchange for operating lease liability | ||
| Ordinary shares issued in connection with notes payable | ||
| Ordinary shares to be issued in connection with notes payable |
Loading...
